{"name":"UPECLIN HC FM Botucatu Unesp","slug":"upeclin-hc-fm-botucatu-unesp","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"First-line Antiretroviral Therapy","genericName":"First-line Antiretroviral Therapy","slug":"first-line-antiretroviral-therapy","indication":"HIV-1 infection, treatment-naïve patients","status":"marketed"},{"name":"ceftriaxone/oxacillin","genericName":"ceftriaxone/oxacillin","slug":"ceftriaxone-oxacillin","indication":"Serious bacterial infections including meningitis, endocarditis, and sepsis","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Comparison of two anesthetic drugs","genericName":"Comparison of two anesthetic drugs","slug":"comparison-of-two-anesthetic-drugs","indication":"Other","status":"marketed"},{"name":"Polidocanol with Glucose","genericName":"Polidocanol with Glucose","slug":"polidocanol-with-glucose","indication":"Varicose veins","status":"marketed"}]}],"pipeline":[{"name":"First-line Antiretroviral Therapy","genericName":"First-line Antiretroviral Therapy","slug":"first-line-antiretroviral-therapy","phase":"marketed","mechanism":"First-line antiretroviral therapy typically combines multiple HIV drugs that inhibit viral reverse transcriptase, protease, or integrase to suppress HIV replication and restore immune function.","indications":["HIV-1 infection, treatment-naïve patients","AIDS prevention and viral load suppression"],"catalyst":""},{"name":"Comparison of two anesthetic drugs","genericName":"Comparison of two anesthetic drugs","slug":"comparison-of-two-anesthetic-drugs","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Polidocanol with Glucose","genericName":"Polidocanol with Glucose","slug":"polidocanol-with-glucose","phase":"marketed","mechanism":"Polidocanol is a sclerosing agent that causes endothelial damage and fibrosis of blood vessel walls, used in combination with glucose as a sclerosant for varicose veins and other vascular lesions.","indications":["Varicose veins","Telangiectasia and spider veins","Venous malformations"],"catalyst":""},{"name":"ceftriaxone/oxacillin","genericName":"ceftriaxone/oxacillin","slug":"ceftriaxone-oxacillin","phase":"marketed","mechanism":"This combination of two beta-lactam antibiotics inhibits bacterial cell wall synthesis through inhibition of penicillin-binding proteins, providing broad-spectrum coverage against gram-positive and gram-negative bacteria.","indications":["Serious bacterial infections including meningitis, endocarditis, and sepsis","Hospital-acquired and community-acquired infections with mixed gram-positive and gram-negative pathogens"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":4,"phaseCounts":{"marketed":4},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}